Overview

Oxytocin Add-on for Stable Depressed Patients

Status:
Terminated

Trial end date:
2015-12-01

Target enrollment:

Participant gender:

Summary

The objective of the study is to compare the efficacy of intranasal oxytocin versus intranasal placebo to improve depression symptoms in patients with Major Depressive Disorder (MDD) or Dysthymia Disorder.

Phase:

N/A

Details

Lead Sponsor:

David Feifel

Treatments:

Oxytocin